Company
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
Prometheus develops medical devices for regenerative medicine. The first product is Ematik: a patch for wound care combining patient's blood with biomaterials. The product is already on the vet market and it will be certified for human applications
Mirandola, Emilia-Romagna, Italy
Send a message
Anglais
Anglais
Prometheus is an Italian innovative Startup working in the field of Medical devices with application on regenerative medicine.
The company, incorporated in November 2017, is based in Mirandola (MO), Italy, one of the most important European Districts for Medical Devices. The team is now composed by 3 co-founders with a background on biotechnologies, 3D printing and device automation
Prometheus is an Italian innovative Startup working in the field of Medical devices with application on regenerative medicine.
The company, incorporated in November 2017, is based in Mirandola (MO), Italy, one of the most important European Districts for Medical Devices. The team is now composed by 3 co-founders with a background on biotechnologies, 3D printing and device automation and an employee working as Marketing & Communication Responsible.
The Team is supported by an official Advisory Board including representatives from the Financial, Scientific and Helathcare Regulatory fields. In particular, Dr. Andrea Chiesi (R&D portfolio manager of Chiesi Farmaceutici S.p.A., one of the most important European pharma companies) is one of the older members of our advisory board, supporting the team in the definition of regulatory steps, related budget and in the establishment of networks.
Prometheus also collaborates with universities, such as the University of Parma and Perugia, that are supporting and validating the project under a scientific, technical and clinical point of view.
The Ematik project for human wound care has been also validated and is now supported by important and well re-known Clinical key opinion leaders, working both in the field of chronic wounds and surgical wounds.
1
Followers